Skip to Content

Notice

Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is canceling the public meeting for the ICH meetings in Brussels, Belgium scheduled for October 5, 2001. The public meeting was announced in the Federal Register of September 7, 2001 (66 FR 46801). It will be rescheduled at a later date.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Kimberly Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001.

Start Signature

Dated: September 25, 2001.

Margaret M. Dotzel,

Associate Commissioner for Policy.

End Signature End Further Info End Preamble

[FR Doc. 01-24528 Filed 9-26-01; 3:57 pm]

BILLING CODE 4160-01-S